Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of pyrazoloacridine given
together with peripheral stem cell or bone marrow transplantation in treating young patients
with high-risk neuroblastoma. Drugs used in chemotherapy use different ways to stop tumor
cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem
cell or bone marrow transplantation may allow the doctor to give higher doses of chemotherapy
drugs and kill more tumor cells.